Astrea Bioseparations Ltd.

In 1987, a Cambridge University working group spun out under the name Affinity Chromatography Limited. Through the years, the name and owner changed, including time as Prometic Bioseparations before being sold in late 2019 and subsequently rebranding to Astrea Bioseparations. We are a Gamma Biosciences company, focused on helping to bring small and large molecule, and advanced therapies to market with industry leading bioseparation adsorbents and resins. Our team is honored to supply reliable, world class resins for more than 21 FDA and EMA approved manufacturing processes. The global experts in providing products & tools for the complete bioseparation workflow.